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Letter to the Editor 
SERUM-FREE MEDIUM FOR LONG-TERM GROWTH, FREEZING, 
CLONING AND FUSION OF MYELOMAS AND HYBRIDOMAS 
Dear Editor: 
A number of laboratories and companies have reported on the 
development of serum-free media for the growth of myelomas and 
hybridomas in tissue culture (1-4,6-9). Due to the different growth 
requirements of different cell lines, these serum-free media gener- 
ally have not been broadly applicable. For example, HB101 (Hana 
Biologies) supported the growth of SP2/0 cells, SP2/O-derived 
hybridomas, human-human hybridomas, etc., but not NS-I and 
NS-l-derived hybridomas (6); the SFH medium described by Kovar 
and Franek (4) was suitable for the growth of F0 myeloma cells and 
T3-03 cells (F0-derived hybridomas) but not X63-Ag8.653 cells 
and PGG-05 cells (X63-Ag8.653-derived hybridomas); the SSF 
medium of Chang et al. (1) supported five hybridoma cells but not 
P3X63Ag8 and 653 myeloma cells; the SFFD/ITES medium of 
Murakami et al. (7) supported MPC11- or SP2/0-derived hybrid- 
omas but not sufficiently NS-l-derived hybridomas; and the media 
of Cleveland et al. (2) supported P3X63-Ag8.653 myelomas and 
some of hybridomas but not M1/75.16.4 rat-mouse hybridomas. 
Our experimental findings indicated that DMI serum-free medium 
supported the growth of all tested cell lines which covered human, 
rat and mouse myelomas, rat-mouse heterohybridomas, mouse- 
mouse homohybridomas, K562 cells etc. (Table 1) (5). It was 
shown that successful growth of hybridoma ina serum-free medium 
in short-term culture did not mean successful adaptation to long- 
term cultivation i  the serum-free medium (4). In the present study 
it was confirmed that DMI could be successfully used to long-term 
TABLE 1 
LONG-TERM CULTIVATION AND DENSITIES OF MYELOMA 
AND HYBRIDOMA CELLS IN SERUM-FREE MEDIUM (DMI) 
Passage 
Cell Period Cell Density Death Rate 
Line (months) Passage No. (Xl04/ral) of CeLls (%) 
Myebma 
SP2/O 16 160 251 7.2 
653 16 161 198 3.2 
P3U1 9 88 193 6.7 
983 9 87 152 5.3 
Hybfidoma 
41RF5 12 118 169 7.4 
94D1 3 27 149 7.7 
21E3 3 30 162 8.5 
13A2 5 49 157 9.2 
13F3 6 60 158 7.0 
32B5 6 58 132 7.0 
A2E5 3 28 139 5.1 
Other  
K562 2 20 
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TABLE 2 
CLONING EFF1CIENCIES OF MYELOMA AND HYBRIDOMA 
LINES FROM SINGLE CELL STAGE IN SERUM-FREE 
MEDIUM (DMI) AND 15% SERUM-SUPPLEMENTED 
MEDIUM (RPS15) 
No, of We~ No. of C~n~ 
~4th Hybrids in thePht~ 
Cell No. of Wells 
Lines Seeded DMI RPSI5 DMI RPSI5 
Myeloma 
SP2/0 96 37 44 46 68 
653 96 43 54 51 83 
P3U1 96 26 50 28 63 
983 96 35 37 51 49 
Hybfidoma 
41RF5 96 38 48 51 70 
13F3 96 20 25 25 28 
culture a variety of cell lines tested (Table 1). Although to date a 
number of serum-free media have been described, the cell densities 
in these media mostly were not superior to 106 cells/ml (1,4,6,8). 
The present results howed that the densities of all cell lines pas- 
saged in DMI were more than 130 X 104 cells/ml when the death 
rate was less than 10% (Table 1), and SP2/O ceils once reached a
maximal density of 299 × 104 cells/ml. In addition, all tested 8 
myeloma nd hybridoma cell lines growing in DMI could be frozen 
in the absence of serum for storage in liquid nitrogen with quantita- 
tive serum-free cell recovery (data not shown). If the cells growing 
in the conventional medium containing 15% newborn calf serum 
(RPS15) were frozen with DMI for storage and, 2 weeks later, 
resurrected with RPS15 for reculture, cell recovery was similar to 
the conventional freezing and resurrection with 20% serum-supple- 
mented medium (RPS20). 
Monoclonal antibody (mAb) production at high titers is a major 
goal of hybridoma technology. The most important factor in deter- 
mining the utility of serum-free media in hybridoma euhure is 
whether mAb secretion is impaired by the removal ofserum compo- 
nents. Our experimental results showed that the hybridoma cells 
cultured in DMI continued to secrete mAbs at levels imilar to those 
obtained in RPS15 (data not shown). 
Of evaluating the quantity of serum-free media, one is to test the 
ability of a serum-free medium to support he clonal growth from 
the single cell stage. McHugh et al. (6) demonstrated that the clon- 
ing efficiencies of SP2/0 and SP2/O-derived hybridomas in 
HB101 medium ranged from 1 to 3% as compared to 69-90% in 
serum-supplemented m ium. Shacter (8) reported that the cloning 
efficiency of a hybridoma in SFM medium was 20% (9/48), 
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TABLE 3 
CELL FUSIONS BETWEEN P3U1 MYELOMA PASSAGED IN 
SERUM-FREE MEDIUM (DMI) AND RODENT SPLEEN CELLS 
IN SERUM-FREE MEDIUM (DMI) AND 20% SERUM- 
SUPPLEMENTED MEDIUM (RPS20) 
Exp. No. of Wells No. of Wells Fusion 
No. a Medium Seeded With Hybrids Frequency b 
I DMI 96 93 2.4 
RPS20 96 96 4.7 
II DMI 96 96 5.0 
RPS20 96 96 6.0 
Mouse-rat fusion (I) and mouse-mouse fusion (II); baverage number of 
colonies per well. 
sensitized mouse spleen cells with myeloma cell lines P3-U1, 
Ag8.653 or NS-1. The result presented here has confirmed that 
DMI medium could be used in the cell fusions of immunized rat or 
mouse spleen cells with SP2/0 or P3U 1 myelomas either passaged 
in DMI medium or obtained from the subcutaneous somatic neo- 
plasm in BALB/c mice with a maximal fusion efficiency of 100% 
(Table 3) and in the isolation of antibody-secreting hybridomas 
(data not shown). Thus, it is concluded that DMI medium may be 
broadly applicable. 
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whereas that obtained in the presence of 10% serum was 50% 
(48/96). Our data (Table 2) showed that the cloning effciencies 
(number of wells with hybrids) obtained in DMI ranged from 21 to 
45% as compared to 26 to 56% in RPS15, and that the number of 
clones grown in the plates varied from 26 to 53% in DMI as com- 
pared to 29 to 86% in RPS15. 
The production of antibody-secreting hybridomas from the fu- 
sions of mouse myeloma cells with spleen cells in serum-free me- 
dium has a number of practical advantages (3). However, whether 
or not serum-free media developed specifically for parental my- 
eloma lines and/or established hybridoma lines can be used in the 
cell fusion between immunized spleen ceils and myeloma cell lines 
and subsequently in the isolation of hybridomas directly after the 
fusion is less clear. Kawamoto et al. (3) reported that the KSLM 
medium could be used in the cell fusion and then in the isolation of 
antibody-secreting hybridomas. When using NS-1 as parental cells, 
the fusion effciencies ranged from 52 to 54%,  while for NS-1-503 
partner, the fusion efficiencies varied from 85 to 92%. Yabe et al. 
(9) indicated that the NYSF-404 medium was able to use for the 
selection of antibody-producing hybridomas after fusion of antigen- 
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